Oculis
Oculis is a Lausanne, Switzerland-based biopharmaceutical company focused on developing products and therapies for eye diseases.
3
Funding Rounds
$129.5m
Money raised
Overview
Oculis is a Lausanne, Switzerland-based biopharmaceutical company focused on developing products and therapies for eye diseases.
- Website:
- Headquarters: Reykjavík
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Oculis has raised a total of $129.5m in funding over 3 rounds.
Key Insights:
- Oculis Series C round, May 2021: $57m
- Oculis May 2021 Series C Funding Round: $57m
- Oculis Series B round, January 2018: $15.5m
Oculis Series C round, May 2021
$57m
Oculis May 2021 Series C Funding Round
$57m
Oculis Series B round, January 2018
$15.5m
Industries
Oculis is active in the following industries: